Risk Factors Update Summary
- Failure to secure Medicare coverage for Optune Lua could lead to significant revenue loss.
- Pending approvals for NSCLC expand Optune's market potential, increasing revenue opportunities significantly.
- Changes in international tax rules could significantly affect the company's future tax payments.
- Transition from pivotal to phase 3 clinical data may impact future regulatory approvals.
- Increased focus on obtaining reimbursement and coverage for products to ensure future financial stability.
- Occasional operating profits instead of limited profits indicate improving financial performance.
- New draft guidance on emerging technologies may impact future product coverage and reimbursement.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1645113&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.